fda bpc-157 compounding status
Definition
A regulatory status referring to the Food and Drug Administration's classification of the synthetic peptide BPC-157, which is currently not approved for human use and has been flagged for its exclusion from the list of bulk drug substances permitted for compounding due to safety and lack of clinical evidence.
The ongoing legal and bureaucratic scrutiny regarding the use of BPC-157 in custom-compounded medications, often sought for athletic recovery or anti-inflammatory purposes despite the absence of formal authorization.
Examples
My gym buddy insisted that his BPC-157 was basically holy water for tendons, despite the FDA clearly thinking otherwise about its compounding status.
Trying to find a pharmacy that treats the FDA's stance on BPC-157 compounding status as a mere polite suggestion is a modern-day treasure hunt for the desperate.
The beauty of the regulatory process is that you can have all the anecdotal evidence in the world, yet the FDA will still insist that BPC-157's compounding status remains firmly in the 'please don't inject that' category.